Research programme: protein-protein interaction antagonists - DICE Therapeutics
Alternative Names: Research-programme-protein-protein-interaction-antagonist-DICE-TherapeuticsLatest Information Update: 28 Feb 2025
At a glance
- Originator DiCE Molecules
- Developer DICE Therapeutics
- Class Small molecules
- Mechanism of Action Protein-protein interaction inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders